Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly susceptible to drawdowns when market sentiment shifts.

Finding the right balance between price and quality can challenge even the most skilled investors. Luckily for you, we started StockStory to help you identify the real opportunities. That said, here is one high-flying stock to hold for the long term and two where the price is not right.

Two High-Flying Stocks to Sell:

Vishay Precision (VPG)

Forward P/E Ratio: 56.7x

Emerging from Vishay Intertechnology in 2010, Vishay Precision (NYSE: VPG) operates as a global provider of precision measurement and sensing technologies.

Why Is VPG Risky?

1. Sales tumbled by 7% annually over the last two years, showing market trends are working against its favor during this cycle
2. Performance over the past five years shows its incremental sales were much less profitable, as its earnings per share fell by 16.2% annually
3. Diminishing returns on capital from an already low starting point show that neither management’s prior nor current bets are going as planned

Vishay Precision is trading at $46.39 per share, or 56.7x forward P/E. To fully understand why you should be careful with VPG, check out our full research report (it’s free).

Surgery Partners (SGRY)

Forward P/E Ratio: 61.5x

With more than 180 locations across 33 states serving as alternatives to traditional hospital settings, Surgery Partners (NASDAQ: SGRY) operates a national network of outpatient surgical facilities including ambulatory surgery centers and short-stay surgical hospitals.

Why Do We Think Twice About SGRY?

1. Underwhelming unit sales over the past two years suggest it might have to lower prices to accelerate growth
2. Estimated sales growth of 2.9% for the next 12 months implies demand will slow from its two-year trend
3. High net-debt-to-EBITDA ratio of 7× could force the company to raise capital at unfavorable terms if market conditions deteriorate

At $12.66 per share, Surgery Partners trades at 61.5x forward P/E. Dive into our free research report to see why there are better opportunities than SGRY.

One High-Flying Stock to Watch:

Helmerich & Payne (HP)

Forward P/E Ratio: 66x

Operating the largest fleet of super-spec rigs in North America with technology that can drill horizontal wells over two miles long, Helmerich & Payne (NYSE: HP) provides drilling rigs and crews to oil and gas companies that need wells drilled to extract hydrocarbons from underground.

Why Should HP Be on Your Watchlist?

1. Annual revenue growth of 25.4% over the last five years was superb and indicates its market share increased during this cycle
2. Revenue base of $4.09 billion gives it economies of scale and some negotiating power with suppliers
3. EBITDA profits and efficiency rose over the last five years as it benefited from some fixed cost leverage

Helmerich & Payne’s stock price of $34.93 implies a valuation ratio of 66x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.